ArticleCancers2025

Apalutamide Monotherapy in Metastatic Hormone-Sensitive Prostate Cancer: A Viable Alternative to First-Generation Anti-Androgen Agents to Avoid the Flare Phenomenon and an Effective Treatment for Achieving Early PSA Response.

Gaetano Facchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.